The Biggest Psychedelic News Stories of the Week – September 11th
Business, Policy, TreatmentCalifornia stands on the cusp of a psychedelic revolution with the TREAT Act and a landmark bill on 'magic mushrooms,' even as Michigan, Congress, and global initiatives from Sweden to Canada expand the horizons of mental health, addiction treatment, and veteran care.
MDMA Successfully Treats PTSD in Another Phase 3 Trial Sponsored by MAPS
Research, Treatment"MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024," says MAPS founder and president Rick Doblin.
The Millennium’s Primer Series: Neuroinflammation as a Barrier to the Success of Psychedelic-Assisted Therapies
Research, TreatmentInitial clinical trials into this exciting frontier have unveiled promising outcomes, showcasing remarkable improvements in clinical results using anti-inflammatory, nanoliposomal products prior to the application of a psychedelic agent.
The Risks of Mixing Psychedelics and Opioids for Chronic Pain
TreatmentThe main risk of mixing psychedelics and opioids for chronic pain is an opioid overdose—a potentially life-threatening condition that should be treated as quickly as possible. Otherwise, it may result in coma, brain damage, and death.
First Psilocybin-Assisted Addiction Recovery Program in U.S. Opens in Oregon
TreatmentOregon pioneers the first Psilocybin-Assisted Addiction Recovery Program in the United States.
From Risk to Resilience: Healthcare Providers and the Psychedelic Therapy Revolution
TreatmentCurrently, MDMA-assisted therapy for PTSD and psilocybin for depression disorders await approval from the FDA. Meanwhile, practitioners are creating spaces to give their patients this revolutionary experience.
New Study Determines Psilocybin Provides ‘Rapid and Sustained Antidepressant Effect’
Research, TreatmentOne of the largest studies yet lends more evidence to the view that psilocybin "may hold promise as a novel intervention for major depressive disorder."
30 Days, 30 Psychedelic Retreats – Lessons Learned From Our Quest to Study Central American Retreats and Their Potential to Heal Minds
Culture, TreatmentMy journey through 30 retreats made it quite clear that every center has a somewhat unique philosophy of care. With much of the science still early and murky, it’s difficult to say that one approach is better or worse than any others.
Psychedelic Therapy As Employee Health Benefit Is Becoming Possible and the First Results Are In
TreatmentNo fewer than 50 companies have shown interest in offering psychedelic therapy to their employees through healthcare plan startup Enthea.
First-Ever Professional Guidelines for Psychedelic-Assisted Therapy Practitioners Now Published by APPA and BrainFutures
TreatmentThe first-ever set of professional practice guidelines for psychedelic-assisted therapy were officially published today.